Kaplan-Meier plots of OS and LFS of 110 total patients and 102 CR patients after anti-CD 19 CAR T-cell therapy. (A-D) On day 30 after anti-CD19 CAR T-cell infusion, 102 of 110 patients achieved morphologic CR. To show long-term efficacy after CAR T-cell therapy, Kaplan-Meier analysis of OS and LFS were performed for both the 110 total patients and 102 CR patients.